FOCAL+ FACULTY

Dr. Kevin Zorn is a former Associate Professor of Urology at the University of Montreal (CHUM) and University of ChicagoPritzker School of Medicine, sub-specializing in robotic procedures, minimally-invasive prostate surgical care and a growing focus on men’s sexual health. He is the founder and director of BPH CANADA clinic where he offer’s Canadian men and abroad access to the end-to-end BPH prostate treatment offerings.

Dr. Zorn attended McGill University for his pre-med Bachelor program, then completed his medical degree followed by residency in urological surgery at McGill. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2005. He has completed a two-year fellowship in oncology (SUO) and endourology (EUS) at the University of Chicago. In 2007, Dr. Zorn also became American Board of Urology certified in urology and a fellow of the American College of Surgeons. After remaining on faculty at the University of Chicago until 2009, Dr. Zorn returned to Canada in 2010 to join the faculty of the Division of Urology at the University of Montreal. Aside from his large surgical volume, he held a number of roles including medical director of robotic surgery and fellowship director for robotics and MIS since 2011. He is also the founder of www.intuitiveurology.com (a global platform for resident urological education materials and self-testing) as well as www.BPHCanada.com (a comprehensive, personalize BPH surgical center to offer all Canadian men rapid access to all BPH surgical modalities).

Dr. Zorn’s career has consistently been hallmarked by research and innovation. Among his many firsts, he was the first in Canada and Québec to use many new BPH technologies including Greenlight XPS, Rezum, iTind, Optilume, Aquablation, Zenflow and Optilume. He has also been the first in Canada to introduce cutting-edge technologies including the Clarius and ButterflyIQ point-of care ultrasounds (POCUS), as well as disposable AMBU4 cystoscopes for faster patient care and safety. He is an early adopter of AI technology (DeepCura, Deepscribe) to help in patient consultation, medical charting, pre- and post-visit followup correspondence to ensure comprehension, compliance of care). Dr Zorn is among the first physicians globally to be named as a Center of Excellence for Rezum and Greenlight vaporization. He is an international speaker and surgical trainer for these techniques. Dr. Zorn is the senior author of the Male LUTS/BPH guidelines for the 2018 and 2023 Canadian Urological Association and has been an invited reviewer of the American Urological Association BPH guidelines. Over the past 20 years, he has now authored 500 peer-reviewed publications and 15 book chapters. With such accolades, Dr. Zorn has become a sought-after speaker, teacher and researcher. He has travelled to lecture, teach and proctor surgery around the world, and is intimately involved with the development of several new, pioneering BPH technologies.

In summary, Dr. Zorn is a world-renown surgeon scientist in the field of urology who continues to make significant contributions to urological education, research and clinical services for men’s voiding dysfunction, BPH, prostate cancer and sexual wellness.